Prostatis Group’s Regents Park Hedged Market Strategy ETF RPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,406
Closed -$205K 108
2022
Q4
$205K Buy
+24,406
New +$210K 0.13% 94

Other funds holding RPHS

Prostatis Group's RPHS Position: Q1 2023 in Review

Prostatis Group sold out of Regents Park Hedged Market Strategy ETF (RPHS) in Q1 2023, closing a stake of 24,406 shares — an estimated $205K sold.

Prostatis Group first reported a position in RPHS in Q4 2022 and held it in 1 quarter. The position peaked at $205K in Q4 2022. 14 funds tracked by Wall St. Rank hold RPHS as of Q1 2023.

  • Prostatis Group reported no remaining Regents Park Hedged Market Strategy ETF position as of Q1 2023 after selling out during the quarter.
  • Prostatis Group sold 24,406 Regents Park Hedged Market Strategy ETF shares in Q1 2023, an estimated $205K.
  • Prostatis Group first reported a position in Regents Park Hedged Market Strategy ETF in Q4 2022 and held it in 1 quarter.
  • Prostatis Group's Regents Park Hedged Market Strategy ETF position peaked at $205K in Q4 2022.
  • 14 funds tracked by Wall St. Rank held Regents Park Hedged Market Strategy ETF as of Q1 2023.

Based on Prostatis Group's 13F filing for Q1 2023, filed 22 May 2023.